IMARC Group’s report titled “Recombinant DNA Technology Market Report by Product (Medical, Non-Medical), Component (Expression System, Cloning Vector), Application (Food and Agriculture, Health and Disease, Environment, and Others), End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Others), and Region 2025-2033”, The global recombinant DNA technology market size reached USD 796.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1,143.4 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033.

Grab a sample PDF of this report: https://www.imarcgroup.com/recombinant-dna-technology-market/requestsample

Factors Affecting the Growth of the Recombinant DNA Technology Industry:

• Increased Investment in Biotechnology:

The recombinant DNA technology market is getting more money from both governments and private companies. This is because people see that biotechnology can change healthcare, farming, and the environment. Governments are funding research, and investors are interested in biotech startups working on new DNA technologies. This money is helping improve tools like CRISPR and create new medical treatments, such as personalized medicine. With more people joining the market, competition is increasing, which encourages new ideas and makes recombinant DNA products more available.

• More Uses in Medicine:

Recombinant DNA technology is being used more in medicine, especially for making biologics and vaccines. As health problems grow, there is more demand for better treatments and vaccines. The COVID-19 pandemic made the use of recombinant DNA technology in vaccine development faster and more effective. Now, pharmaceutical companies are investing in new treatments like gene therapies and monoclonal antibodies to solve health problems. Health regulators are also becoming more supportive, helping recombinant DNA products grow in the market.

• Rising Awareness and Acceptance:

More people are learning about biotechnology and accepting recombinant DNA technology. As people understand that GMOs and recombinant products are safe and beneficial, their opinions are changing. This is important for the acceptance of genetically modified crops, which can grow better and resist pests and diseases. Biotech companies are educating the public and providing clear information. With consumers demanding more sustainably produced food, the recombinant DNA technology market is benefiting, with more uses in farming being adopted.

We explore the factors propelling the recombinant DNA technology market growth, including technological advancements, consumer behaviors, and regulatory changes.

Leading Companies Operating in the Global Recombinant DNA Technology Industry:

• Amgen Inc
• Cibus
• F.Hoffmann-La Roche Ltd
• GenScript
• GlaxoSmithKline plc.
• Horizon Discovery Group plc
• Merck KGaA
• New England Biolabs
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi S.A
• Syngene International Ltd (Biocon Limited)

Recombinant DNA Technology Market Report Segmentation:

Breakup By Product:

• Medical
  • Therapeutic Agent
  • Human Protein
  • Vaccines
• Non-Medical
  • Biotech Crops
  • Specialty Chemicals
  • Others

Breakup By Component:

• Expression System
• Cloning Vector

Breakup By Application:

• Food and Agriculture
• Health and Disease
• Environment
• Others

Breakup By End User:

• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutes
• Others

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Recombinant DNA Technology Market Trends:

The recombinant DNA technology market is expected to grow a lot in 2024. One major trend is personalized medicine, where treatments are made based on a person’s unique genetics. This is especially important as more people face genetic disorders and chronic diseases. The agriculture industry is also using recombinant DNA to improve crop strength and yields, especially with climate change affecting farming. Laws and regulations are changing to support these innovations, making it easier for the market to grow. Overall, the recombinant DNA technology market will expand in 2024 due to scientific progress, supportive rules, and growing demand from consumers.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145